FILE:PRGO/PRGO-8K-20041029102431.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2004 PERRIGO COMPANY --------------- (Exact name of registrant as specified in its charter) MICHIGAN 0-19725 38-2799573 - --------------- ------------- ----------------- (State of other (Commission (IRS Employer Jurisdiction of File Number) Identification Incorporation) No.) 515 Eastern Avenue, Allegan, Michigan 49010 - ---------------------------------------- --------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (269) 673-8451 Not Applicable - -------------------------------------------------------------------------------- (Former name or address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. Regulation FD Disclosure On October 29, 2004, The Perrigo Company held its Annual Shareholders' Meeting at the Perrigo Corporate Office, Allegan, Michigan. The Annual Shareholders' Meeting slides presented are Exhibit 99. Certain statements in these slides are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. Please see the "Cautionary Note Regarding Forward-Looking Statements" on pages 27 - 33 of the Company's Form 10-K for the year ended June 26, 2004 for a discussion of certain important factors that relate to forward-looking statements contained in this press release. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The information in this Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. ITEM 9.01. Financial Statements and Exhibits (c) Exhibits 99 Annual Shareholders' Meeting Slides.
SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERRIGO COMPANY (Registrant) Dated: October 29, 2004 By: /s/Douglas R. Schrank ----------------------------------- Douglas R. Schrank Executive Vice President and Chief Financial Officer (Principal Accounting and Financial Officer)
Exhibit Index Exhibit 99 - Annual Shareholders' Meeting Slides, furnished solely pursuant to Item 7.01 of Form 8-K.

EXHIBIT 99 WELCOME TO THE 2004 ANNUAL MEETING OF SHAREHOLDERS Allegan, Michigan October 29, 2004 [PERRIGO LOGO] 1
THE STORE BRAND MARKET LEADER [PICTURE] SUPPLIER TO MORE THAN 300 FOOD, DRUG AND MASS MERCHANDISE CHAINS... INVENTED THE CATEGORY. [PERRIGO LOGO] 2
FINANCIAL PERFORMANCE SALES [PERFORMANCE GRAPH] (Millions) Note: Reconciliation to GAAP results provided at www.perrigo.com/investor. [PERRIGO LOGO] 3
FINANCIAL PERFORMANCE NET INCOME [PERFORMANCE GRAPH] (Millions) (Adjusted for stock option compensation expense, tax benefit, litigation settlement) (Dollars) Note: Reconciliation to GAAP results provided at www.perrigo.com/investor. [PERRIGO LOGO] 4
FINANCIAL PERFORMANCE RETURN ON AVERAGE ASSETS, AVERAGE EQUITY [PERFORMANCE GRAPH] (PERCENT) (Adjusted for stock option compensation expense) [PERRIGO LOGO] 5
2004 HIGHLIGHTS - - Strong Financial Position - - Cash Dividend Increase - - Productivity Gains - - Growth - Strong position in core businesses - U.K. expansion - Generic Rx business entry [PERRIGO LOGO] 6
GROWTH STRATEGY Long-Term Objectives - 10% EXISTING BUSINESS - 5% - - Market growth - - New products - - Share gains ACQUISITIONS - 5% - - Complementary businesses - - OTC niche products - - Nutritional companies - - Geographic expansion - - Generic Rx entry [PERRIGO LOGO] 7
LORATADINE (CLARITIN(R)) [PICTURE] [PERRIGO LOGO] 8
NICOTINE GUM (NICORETTE(R)) [PICTURE] [PERRIGO LOGO] 9
GROWTH STRATEGY Generic Prescription Drugs - - Extension of existing OTC pharmaceutical business - - Investment stage - - Three generic drug filings; 8 - 10 in fiscal 2005 - - Received first prescription drug approval - - Commitment to generic Rx [PERRIGO LOGO] 10
[PERRIGO LOGO] COMMITTED TO DELIVERING AFFORDABLE HIGH-QUALITY HEALTH CARE PRODUCTS. [PERRIGO LOGO] 11


